Iridia, Inc. is a California-based molecular sciences company in the biopharma sector. According to filings, it spends money lobbying Congress mainly on fiscal year 2026 defense appropriations and related Department of Defense procurement issues, including supply chain authentication, and has also raised budget/appropriations and criminal justice topics. It hired the lobbying firm Smith Garson and reported $75,000 over five filings.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BRETT GARSON
The latest disclosures for this client.
SMITH GARSON
Q1SMITH GARSON
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
SMITH GARSON
JOHN BAIR
SMITH GARSON
mr BENJAMIN ODENDAHL
SMITH GARSON
SMITH GARSON
Q3SMITH GARSON
Q2SMITH GARSON
Q1SMITH GARSON
RR